🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Significance to VA: There is a lack of prospective longitudinal studies inv...
Status
Not Yet Recruiting
Location
Zablocki Veterans Affairs Medical Center
Start Date
2026-07-01
Trial ID
NCT07367139
Treatments Being Tested
Purpose: To study the associations between visual functions and the retinal...
Status
Completed
Location
Naitonal Taiwan University Hospital
Start Date
2008-08
Trial ID
NCT00784901
This phase I trial studies the side effects and best dose of AR-42 when giv...
Status
Completed
Location
Cincinnati Children's Hospital
Start Date
2013-09-17
Trial ID
NCT01798901
Treatments Being Tested
This phase II trial studies how well radiation therapy works in treating po...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2013-05
Trial ID
NCT01754519
Nasal obstruction is a very subjective sensation but it's also a frequent r...
Status
Completed
Location
Groupe Hospitalier Paris Saint Joseph
Start Date
2016-12-05
Trial ID
NCT03331107
This is a prospective study investigating the role of tissue-resident immun...
Status
Recruiting
Location
Nanfang Hospital, Southern Medical University
Start Date
2024-11-16
Trial ID
NCT06708507
The aim of this study was to verify the clinical reliability of ankle dorsi...
Status
Completed
Location
Filipe Abdalla
Start Date
2017-01-25
Trial ID
NCT03213015
Treatments Being Tested
Autonomic dysreflexia (AD) is a syndrome of unbalanced response of the symp...
Status
Unknown
Location
Department of Rehabilitation and Sports Medicine, University Hospital Motol
Start Date
2023-01-01
Trial ID
NCT05024487
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of vaccine the...
Status
Completed
Location
Mayo Clinic
Start Date
2006-11-30
Trial ID
NCT00450814
This is a non-randomized phase II trial of denosumab at 120 mg subcutaneous...
Status
Completed
Location
Stony Brook University Cancer Center
Start Date
2015-11
Trial ID
NCT02613416
Treatments Being Tested